These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 17216017)
1. [Primary antiphospholipid syndrome and hyperhomocysteinemia: a study of a group of 29 patients]. Del Ross T; Ruffatti A; Tonello M; Salmistraro G; Calligaro A; Favaro M; Ciprian M; Todesco S Reumatismo; 2006; 58(4):283-7. PubMed ID: 17216017 [TBL] [Abstract][Full Text] [Related]
2. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Shirokova IE; Lisitskaia TL Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India. Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and renal involvement. Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697 [TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953 [TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients. Chen WH; Lin HS; Kao YF; Lan MY; Liu JS Clin Appl Thromb Hemost; 2007 Oct; 13(4):398-403. PubMed ID: 17911191 [TBL] [Abstract][Full Text] [Related]
7. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity. Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236 [TBL] [Abstract][Full Text] [Related]
8. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study). Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D; Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216 [TBL] [Abstract][Full Text] [Related]
9. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome. Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664 [TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome with only antiphosphatidylethanolamine antibodies: report of 20 cases]. Desauw C; Hachulla E; Boumbar Y; Bouroz-Joly J; Ponard D; Arvieux J; Dubucquoi S; Fauchais AL; Hatron PY; Devulder B Rev Med Interne; 2002 Apr; 23(4):357-63. PubMed ID: 11980311 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome. Núñez-Álvarez CA; Hernández-Molina G; Bermúdez-Bermejo P; Zamora-Legoff V; Hernández-Ramírez DF; Olivares-Martínez E; Cabral AR Thromb Res; 2019 Feb; 174():141-147. PubMed ID: 30612005 [TBL] [Abstract][Full Text] [Related]
12. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI Lupus; 2007; 16(10):782-7. PubMed ID: 17895300 [TBL] [Abstract][Full Text] [Related]
13. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
14. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome. Del Ross T; Ruffatti A; Cuffaro S; Tonello M; Calligaro A; Favaro M; Facchinetti M; Hoxha A; Punzi L Thromb Res; 2015 Nov; 136(5):883-6. PubMed ID: 26410418 [TBL] [Abstract][Full Text] [Related]
15. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
16. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome. Kopytek M; Natorska J; Undas A Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Kaul M; Erkan D; Sammaritano L; Lockshin MD Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473 [TBL] [Abstract][Full Text] [Related]